| For: | Vercauteren K, Mesalam AA, Leroux-Roels G, Meuleman P. Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization. World J Gastroenterol 2014; 20(43): 15975-15991 [PMID: 25473151 DOI: 10.3748/wjg.v20.i43.15975] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i43/15975.htm |
| Number | Citing Articles |
| 1 |
Ahmed Mesalam, Koen Vercauteren, Philip Meuleman. Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance. Viruses 2016; 8(6) doi: 10.3390/v8060176
|
| 2 |
Jih-Kai Huang, Hsiang-Chun Lee. Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL). International Journal of Molecular Sciences 2022; 23(8) doi: 10.3390/ijms23084300
|
| 3 |
Lucy Rivett, Graeme Alexander. Is the conquest of Hepatitis C imminent?. Expert Reviews in Molecular Medicine 2019; 21 doi: 10.1017/erm.2019.3
|
| 4 |
Alaa F. Bakr, Ping Shao, Mohamed A. Farag. Recent advances in glycyrrhizin metabolism, health benefits, clinical effects and drug delivery systems for efficacy improvement; a comprehensive review. Phytomedicine 2022; 99 doi: 10.1016/j.phymed.2022.153999
|
| 5 |
Niklas Ebersberger, Gabrielle Vieyres, Thomas Krey. Lipoprotein receptors in hepatitis C virus entry — a structural view. Current Opinion in Virology 2026; 76 doi: 10.1016/j.coviro.2026.101555
|
| 6 |
E. I. Temnik, D. Y. Konstantinov, L. L. Popova. Characteristics of lipid metabolism disorders in patients with coronavirus infection-COVID-19 with chronic hepatitis C. Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH) 2023; 13(5) doi: 10.20340/vmi-rvz.2023.5.CLIN.11
|
| 7 |
Alankrita Rani, Julia T. Stadler, Gunther Marsche. HDL-based therapeutics: A promising frontier in combating viral and bacterial infections. Pharmacology & Therapeutics 2024; 260 doi: 10.1016/j.pharmthera.2024.108684
|
| 8 |
Julien A. Menard, Myriam Cerezo-Magaña, Mattias Belting. Functional role of extracellular vesicles and lipoproteins in the tumour microenvironment. Philosophical Transactions of the Royal Society B: Biological Sciences 2018; 373(1737) doi: 10.1098/rstb.2016.0480
|
| 9 |
Makutiro Ghislain Masavuli, Danushka K. Wijesundara, Alexander Underwood, Dale Christiansen, Linda Earnest-Silveira, Rowena Bull, Joseph Torresi, Eric J. Gowans, Branka Grubor-Bauk. A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01145
|
| 10 |
Chelsea Pinkham, Aslaa Ahmed, Nicole Bracci, Aarthi Narayanan, Kylene Kehn-Hall. Host-based processes as therapeutic targets for Rift Valley fever virus. Antiviral Research 2018; 160 doi: 10.1016/j.antiviral.2018.10.004
|
| 11 |
Claudio M. Fader Kaiser, Patricia S. Romano, M. Cristina Vanrell, Cristian A. Pocognoni, Julieta Jacob, Benjamín Caruso, Laura R. Delgui. Biogenesis and Breakdown of Lipid Droplets in Pathological Conditions. Frontiers in Cell and Developmental Biology 2022; 9 doi: 10.3389/fcell.2021.826248
|
| 12 |
Ximenya Glauce da Cunha Freire Lopes, Roque Ribeiro da Silva Júnior, Fernando Liberalino Fernandes, Laura Andrade Custódio de Oliveira, Vania Sousa Andrade, Fabiana Lima Bezerra, Josélio Maria Galvão de Araújo, Jenner Chrystian Veríssimo de Azevedo, Thales Allyrio Araújo de Medeiros Fernandes, José Veríssimo Fernandes. Epigenetic Mechanisms Involved in Hcv Infection and Human HCC. International Journal of Molecular Sciences 2025; 26(24) doi: 10.3390/ijms262412045
|
| 13 |
Waleed Ezzat Madboly, Magdi G. Shehata, Michael Sobhy M. Nashed, Ahmed M. Abu-Dief. Using power of calculated electrons to cut, analyze and exterminate the outer and the inner biological elements of hepatitis C virus without blood parameters disorders: In vitro study: low potential codified ions for hepatitis therapy. Asian Journal of Applied Science and Engineering 2022; 11(1) doi: 10.18034/ajase.v11i1.16
|
| 14 |
Gustavo Henrique De Puy e SOUZA, Luciana Diniz SILVA, Diego Alves VIEIRA, Gifone Aguiar ROCHA, Agnaldo Soares LIMA, Paula Vieira Teixeira VIDIGAL. HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND SYSTEMIC ARTERIAL HYPERTENSION ARE ASSOCIATED WITH HEPATIC NECROINFLAMMATORY ACTIVITY IN PATIENTS WITH CHRONIC HEPATITIS C. Arquivos de Gastroenterologia 2023; 60(3) doi: 10.1590/s0004-2803.230302023-03
|
| 15 |
Alok Bharadwaj, Manas Taneja, Sneha Dubey, Aditya Saxena. Very low-density lipoprotein and the human health. World Journal of Experimental Medicine 2026; 16(1): 117024 doi: 10.5493/wjem.v16.i1.117024
|
| 16 |
Germana Grassi, Giorgia Di Caprio, Gian Maria Fimia, Giuseppe Ippolito, Marco Tripodi, Tonino Alonzi. Hepatitis C virus relies on lipoproteins for its life cycle. World Journal of Gastroenterology 2016; 22(6): 1953-1965 doi: 10.3748/wjg.v22.i6.1953
|
| 17 |
Hung-Yu Sun, Pin-Nan Cheng, Chiung-Ying Tseng, Wei-Jen Tsai, Yen-Cheng Chiu, Kung-Chia Young. Favouring modulation of circulating lipoproteins and lipid loading capacity by direct antiviral agents grazoprevir/elbasvir or ledipasvir/sofosbuvir treatment against chronic HCV infection. Gut 2018; 67(7) doi: 10.1136/gutjnl-2017-313832
|
| 18 |
Ahmed Atef Mesalam. Hepatitis C Virus Vaccine Development: A Step Forward. The Journal of Infectious Diseases 2021; 223(11) doi: 10.1093/infdis/jiaa644
|
| 19 |
Rania H. Khalifa, Dalia A. Labib, Mohamed A. Kamel, Rasha Mohamad Hosny Shahin, Dina M. Rasheed Bahgat, Nermine Magdi Riad, Engy El Khateeb, Amr M. El‐deeb, Marwa Hassan. Role of ApoB‐516C/T promoter gene polymorphism in the risk of Hepatitis C virus infection in Egyptian patients and in gender susceptibility. Journal of Medical Virology 2017; 89(9) doi: 10.1002/jmv.24815
|
| 20 |
Vladimir Alexei Morozov, Sylvie Lagaye. Hepatitis C virus: Morphogenesis, infection and therapy. World Journal of Hepatology 2018; 10(2): 186-212 doi: 10.4254/wjh.v10.i2.186
|
| 21 |
Malgorzata Sidorkiewicz. Hepatitis C Virus Uses Host Lipids to Its Own Advantage. Metabolites 2021; 11(5) doi: 10.3390/metabo11050273
|
| 22 |
Yoshio Aizawa, Nobuyoshi Seki, Tomohisa Nagano, Hiroshi Abe. Chronic hepatitis C virus infection and lipoprotein metabolism. World Journal of Gastroenterology 2015; 21(36): 10299-10313 doi: 10.3748/wjg.v21.i36.10299
|